Variants with large effects on blood lipids and the role of cholesterol and triglycerides in coronary disease. - Wikidata - wikimedia - TriplyDB

Variants with large effects on blood lipids and the role of cholesterol and triglycerides in coronary disease.

Variants with large effects on blood lipids and the role of cholesterol and triglycerides in coronary disease.

http://www.wikidata.org/entity/Q39804212

about

Mendelian randomization in cardiometabolic disease: challenges in evaluating causality.Parallel evolution of genes controlling mitonuclear balance in short-lived annual fishes Haplotypes on pig chromosome 3 distinguish metabolically healthy from unhealthy obese individuals.Obesity, metabolic factors and risk of different histological types of lung cancer: A Mendelian randomization study Identification of eight genetic variants as novel determinants of dyslipidemia in Japanese by exome-wide association studies.Divergent pathway of lipid profile components for cardiovascular disease and mortality events: Results of over a decade follow-up among Iranian population.Genetic Factors of the Disease Course After Sepsis: Rare Deleterious Variants Are Predictive.Angiopoietin-like protein 4 and cardiovascular function in COPD.Selection against variants in the genome associated with educational attainment Integrative variants, haplotypes and diplotypes of the CAPN3 and FRMD5 genes and several environmental exposures associate with serum lipid variables Utilizing nutritional genomics to tailor diets for the prevention of cardiovascular disease: a guide for upcoming studies and implementations.Human genetic insights into lipoproteins and risk of cardiometabolic disease.HDL as a Causal Factor in Atherosclerosis: Insights from Human Genetics.Angiopoietin-like 4: A molecular link between insulin resistance and rheumatoid arthritis.Comprehensive genotyping in dyslipidemia: mendelian dyslipidemias caused by rare variants and Mendelian randomization studies using common variants.Genetics of Triglycerides and the Risk of Atherosclerosis.Genetics of cardiovascular diseases: lessons learned from a decade of genomics research in Iceland.ANGPTL3 Deficiency and Protection Against Coronary Artery Disease.Clinical Perspectives of Genetic Analyses on Dyslipidemia and Coronary Artery Disease.The angiopoietin-like protein ANGPTL4 catalyzes unfolding of the hydrolase domain in lipoprotein lipase and the endothelial membrane protein GPIHBP1 counteracts this unfolding.Reducing exposure to cardiovascular risk factors: the legacy of prevention.Multidimensional regulation of lipoprotein lipase: impact on biochemical and cardiovascular phenotypes.Genetic Risk and Altering Lipids With Lifestyle Changes and Metformin: Is Fate Modifiable?Exome chip meta-analysis identifies novel loci and East Asian-specific coding variants that contribute to lipid levels and coronary artery disease.Common, low-frequency, and rare genetic variants associated with lipoprotein subclasses and triglyceride measures in Finnish men from the METSIM study.LPL gene Pvu II polymorphism and hypertriglyceridemia: a meta-analysis involving 1,640 subjects.Extending the MR-Egger method for multivariable Mendelian randomization to correct for both measured and unmeasured pleiotropy.Rare non-coding variants are associated with plasma lipid traits in a founder population.Estimating and testing direct genetic effects in directed acyclic graphs using estimating equations.HDL Cholesterol Metabolism and the Risk of CHD: New Insights from Human Genetics.Whole-Genome Sequencing in Common Respiratory Diseases. Ready, Set, Go!Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease.Identity-by-Descent Mapping Identifies Major Locus for Serum Triglycerides in Amerindians Largely Explained by an APOC3 Founder Mutation.An exome-wide sequencing study of lipid response to high-fat meal and fenofibrate in Caucasians from the GOLDN cohort.Insights from population-based analyses of plasma lipids across the allele frequency spectrum.Liraglutide protects cardiac function in diabetic rats through the PPARα pathway.ApoCIII as a Cardiovascular Risk Factor and Modulation by the Novel Lipid-Lowering Agent Volanesorsen.Genome-wide analysis yields new loci associating with aortic valve stenosis.A rare splice donor mutation in the haptoglobin gene associates with blood lipid levels and coronary artery disease.Absence of ANGPTL4 in adipose tissue improves glucose tolerance and attenuates atherogenesis.

P2860

Q30234302-218BD80C-E2A7-41FD-AA6C-4BC8CB9DD081 Q33638908-20D6BB03-1CAA-4A35-9FC0-3506B8A6B2F1 Q33752000-FECD13A1-34ED-4EEB-8B26-8B98581D000F Q33778268-354E11FA-AD99-4331-9BBD-18AD3EC08FB1 Q33889023-15A4E6E8-3EDC-4403-87F8-5B72DD565B96 Q37035438-A93B8771-B806-4E96-BFAF-393D18EC248D Q37363494-C2254B3A-76C4-4A33-9D9A-534970A47066 Q37464058-1F7A0939-B6B5-4587-96AD-80CE934F059F Q37626196-95B6C271-6B4A-4C88-8844-BCE5979F0B95 Q37736278-5850C6F6-C662-4CB7-B9BA-DD89289B4F4E Q38740539-26DCB52F-B470-4D7E-A152-34EB315F9718 Q38774074-ED40829F-F07D-45A6-AAD1-9FDDD454BC33 Q38992139-829323B7-55A4-4231-9F24-D24E87ED41D4 Q39048436-37F528E0-BFB6-489F-A5E1-95B2CDEA1805 Q39068223-6E74A91B-EB2F-4891-B37E-E4437880D44F Q39324048-47F2FC75-E357-4A77-8514-6664BA4FADC9 Q39443092-A509FF76-886B-4B05-AE33-EDB99FAFB45B Q40254292-C270E345-446B-4204-9C23-B4F92B9BC2C5 Q42244280-9CA843CA-2D00-44CE-A102-42EFDD174FDD Q42355233-5010DC5A-05D0-4BB2-B47E-0E0C3336F4C5 Q42384651-87C8E86E-B5C4-4F3E-9BEA-717F33AF9D36 Q42400268-EF9F6F78-A3BA-47D3-A582-2E1998BD8900 Q45516535-1E1ADEA2-3B0D-4061-ACD6-5E290E8BA8D5 Q46033907-830BAFB9-56F1-4C3A-8031-A640E3EB3CD1 Q47124663-15E34466-E310-4062-AB06-0770C5EFDE48 Q47126650-7351D007-1E7E-4C1C-9B94-938A6402D08B Q47138286-EC175895-4B49-4506-A56F-4811954509A1 Q47143371-BB858B1F-7CAA-49CB-A235-CAF9A7DEE54B Q47573012-97F9A9F8-BABA-48BA-A372-578C2B3771E7 Q47657807-E395C0EE-A4A1-4DEE-800C-D48F63313F6E Q47833625-7B95768B-A88B-4121-8EEF-68BDBC8AC710 Q47877816-F9EEA563-FC42-4779-AFEF-F47C541C6BB2 Q48570311-CA586AD7-A203-473F-BBA7-957526B2BB2D Q49791772-36942D3F-F64D-422C-9C58-41CDCF2214DB Q49967906-CE6761CF-02CA-43F7-A845-D47FD7614CDE Q50026330-7BC1D1B1-2D51-47CB-AA93-3971C6453453 Q50075898-5294CF8F-64D8-46EB-B49B-2B897E1CF591 Q50420617-A2FBCC6B-DE4F-48B4-AD06-8B9A38B0D90B Q50921046-0F2B5985-E191-4BC3-B80A-965AC14BFC9B Q52644015-B301F1F3-B2E7-4F03-83C1-0E57D1AA44CE

P2860

Variants with large effects on blood lipids and the role of cholesterol and triglycerides in coronary disease.

http://www.wikidata.org/entity/Q39804212

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Variants with large effects on ...... lycerides in coronary disease.

@en

Variants with large effects on ...... lycerides in coronary disease.

@nl

type

label

Variants with large effects on ...... lycerides in coronary disease.

@en

Variants with large effects on ...... lycerides in coronary disease.

@nl

prefLabel

Variants with large effects on ...... lycerides in coronary disease.

@en

Variants with large effects on ...... lycerides in coronary disease.

@nl

P1433

Q39804212-C94C7A6D-3C80-4EA6-95D3-3471BE9C2486

P1476

Q39804212-E5616508-BA72-4418-B69E-8BDB1CE7F16A

P2093

Q39804212-0E24BF72-1CCD-4E5A-871E-FF35FB54F425

Q39804212-1EA26639-A98D-4F26-A674-7CC7EAC73BE2

Q39804212-2BBD9C5C-7B82-45E4-9619-1FA12461A0CF

Q39804212-32180E29-FF7D-4F2C-B67C-9E07FAEA26DE

Q39804212-41D083D7-C273-4A20-97B5-52965228A6B1

Q39804212-4A70E826-29CF-41F6-BEAC-F475DF158929

Q39804212-5E934B47-2350-4AD9-8456-8065106FC09E

Q39804212-64B09EA0-1560-4D7C-8311-88BFF8EC5AE7

Q39804212-6C39F8A8-D76E-4DD7-85D4-DD93A2B45472

Q39804212-761EDD75-4EE6-414A-A188-630F732F81CA

P2860

Q39804212-04D5FBFE-FAD6-4F75-9BB4-00F725C31201

Q39804212-0F82A114-3E75-4CD4-8B12-B0BC2DABB537

Q39804212-1EE6CD94-DDA7-4F88-BE02-1E59C5839DE7

Q39804212-252548BF-14FC-4874-AC74-E132217A460A

Q39804212-2F841868-EF06-4025-9D0C-E38F77F26E1C

Q39804212-3035E54C-8FF3-4778-889C-E799C076FEDC

Q39804212-363C0D39-5D4A-4010-9260-8F26E38E353F

Q39804212-36EAC9FB-8516-41BC-91A5-95E57A2B02B9

Q39804212-3721A0D6-AD7E-467F-88E1-2F5FC73D196C

Q39804212-3A480ABF-6427-4EA1-BEF7-C0D0D02452B6

P2888

Q39804212-1286527E-6E16-49F2-A1D5-B9300CE9D801

P304

Q39804212-ADA546F9-5A75-45BB-9F10-4C5D9A63AF5A

P31

Q39804212-3AFE8E18-1A61-4F24-B790-B4CBB76224EE

P356

Q39804212-5F3F3C45-F6EF-489F-8FFF-CECA5CAF63C8

P407

Q39804212-E713ED1E-7C1B-43E5-95B1-79BDCE88090C

P433

Q39804212-6FA4112A-95E3-4A42-93C3-15C33578A699

P478

Q39804212-36C2C5A4-9DAC-4E6C-988D-1718D35E939B

P50

Q39804212-33336EBC-B778-404A-9D7C-E92798A9EF4A

Q39804212-50D1C0EF-EBE8-47B6-81E5-0E12A06FF3A5

Q39804212-696B9B84-598B-48D2-A2EC-5525B8B726BE

Q39804212-6B8C75BA-BEE6-493C-8DCE-9BB999538131

Q39804212-81C04F9B-69D7-4E98-A373-FB5CB1B4E3E4

Q39804212-906C3E81-F5C5-4BCE-A743-EEA17389D93B

Q39804212-A3685AA0-442D-4E4E-9CEC-B068560C8C92

Q39804212-A3C0A37B-0E62-4676-AF6F-B884893E9BEB

Q39804212-AE62CC53-D396-4705-B8D1-1B1E15D9DEFA

Q39804212-B2D1E4DE-665A-4F9C-B090-BA7AE310568C

P577

Q39804212-0CDD948F-349A-4464-B92F-EAD48B2D1516

P6179

Q39804212-E00AD870-A70B-47FD-A551-F310B14652BC

P698

Q39804212-4F8B1614-3AD6-4CED-8212-FDA55F41F991

P921

Q39804212-E8362D6C-ADA3-4280-A5EB-6BD54E6BC7FB

P356

P1433

Nature Genetics

P1476

Variants with large effects on ...... lycerides in coronary disease.

@en

P2093

Allan I Levey

http://www.w3.org/2001/XMLSchema#string

Anna Helgadottir

http://www.w3.org/2001/XMLSchema#string

Arshed A Quyyumi

http://www.w3.org/2001/XMLSchema#string

Asgeir Sigurdsson

http://www.w3.org/2001/XMLSchema#string

Aslaug Jonasdottir

http://www.w3.org/2001/XMLSchema#string

Asmundur Oddsson

http://www.w3.org/2001/XMLSchema#string

Audur Magnusdottir

http://www.w3.org/2001/XMLSchema#string

Dorine W Swinkels

http://www.w3.org/2001/XMLSchema#string

Eirikur Hjartarson

http://www.w3.org/2001/XMLSchema#string

Gardar Sveinbjornsson

http://www.w3.org/2001/XMLSchema#string

P2860

Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature

Severe hypertriglyceridemia in human APOC1 transgenic mice is caused by apoC-I-induced inhibition of LPL

dbSNP: the NCBI database of genetic variation

Fast and accurate short read alignment with Burrows-Wheeler transform

Association of apolipoprotein E genotypes with lipid levels and coronary risk

Common variants associated with plasma triglycerides and risk for coronary artery disease

Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor

A common variant on chromosome 9p21 affects the risk of myocardial infarction

Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study

A receptor-mediated pathway for cholesterol homeostasis

P2888

P304

634-639

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NG.3561

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P50

Gudmar Thorleifsson

Unnur Þorsteinsdóttir

Valgerdur Steinthorsdottir

Daniel F Gudbjartsson

Solveig Gretarsdottir

Aslaug Jonasdottir

Ingileif Jonsdottir

Lambertus Kiemeney

P577

2016-05-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1002276775

http://www.w3.org/2001/XMLSchema#string

P698

27135400

http://www.w3.org/2001/XMLSchema#string

P921